Literature DB >> 15100902

[Some epidemiological features of extrapulmonary tuberculosis registered in the tuberculous struggle dispensaries in Isparta].

Rezan Demiralay1.   

Abstract

This work was done to investigate some epidemiological features of extrapulmonary tuberculosis in Tuberculous Struggle Dispensaries in Isparta between the years 1986-1997. For this purpose, 284 extrapulmonary tuberculosis patients who registered in Isparta, Yalvaç and Eğirdir Tuberculous Struggle Dispensaries were reviewed retrospectively. In Isparta, during the 12 year period it was found that the incidence of extrapulmonary tuberculosis changed between 13.0% and 36.8% (average 21.7%). The most common sites of the disease were pleura (52.8%) and lymph nodes (26.0%). The highest rate of the cases was found in the age group of 20-29. Extrapulmonary tuberculosis except the lymph nodes increased steadily with age. Although the average man/woman ratio was 1.6, a sex predominance in some forms of disease was found. It was concluded that extrapulmonary tuberculosis forms an important fraction of the total cases of tuberculosis and occurs in many organs in different age groups in Isparta.

Entities:  

Mesh:

Year:  2003        PMID: 15100902

Source DB:  PubMed          Journal:  Tuberk Toraks        ISSN: 0494-1373


  3 in total

1.  Demographic and microbial characteristics of extrapulmonary tuberculosis cases diagnosed in Malatya, Turkey, 2001-2007.

Authors:  Selami Gunal; Zhenhua Yang; Mansi Agarwal; Mehmet Koroglu; Zeynep Kazgan Arıcı; Riza Durmaz
Journal:  BMC Public Health       Date:  2011-03-08       Impact factor: 3.295

2.  Comparative analysis of pulmonary and extrapulmonary tuberculosis of 411 cases.

Authors:  Aysel Sunnetcioglu; Mahmut Sunnetcioglu; Irfan Binici; Ali Irfan Baran; Mustafa Kasım Karahocagil; Muhammed Rıdvan Saydan
Journal:  Ann Clin Microbiol Antimicrob       Date:  2015-06-24       Impact factor: 3.944

3.  Assessment of Extrapulmonary Tuberculosis in Two Provinces of Turkey.

Authors:  Dursun Tatar; Gunes Senol; Serpil Alptekin; Ebru Gunes; Mert Aydin; Ozdal Gunes
Journal:  Iran J Public Health       Date:  2016-03       Impact factor: 1.429

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.